<div><h1>HERCEPTIN HELPS DELIVER A WARHEAD </h1><p>Roche and ImmunoGen reported on a "guided missile" combination drug called T-DM1 that shrank tumors by 30% or more in one-third of critically ill, advanced breast cancer patients in a trial. The therapy combines Roche's Herceptin with a second, potent cancer-killing drug ...

<div id="subtitle">Novel drug combo boosts survival of breast cancer patients with advanced disease, study finds</div><div><p>Some women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women who had stopped ...

<div><p>ZURICH (Reuters) - Roche Holding AG said on Wednesday three studies on its drugs used to treat early and advanced breast cancer showed good results.</p><p>The Swiss drugmaker, the world's largest maker of cancer drugs, was due to present the results in coming days at the San Antonio ...

<div><p>* Biotech drugs to dominate 2014 blockbuster league table</p><p>* Led by Avastin, Humira, Rituxan, Enbrel, Lantus, Herceptin</p><p>* Biotech to account for 50 pct of top 100 drugs - Evaluate</p><p>LONDON (Reuters) - The world's six biggest-selling drugs in ...